Diabetes
Bromocriptine appears to drop BP, improve arterial stiffness in teens with type 1 diabetes
Bromocriptine, a drug previously used to treat adults with type 2 diabetes and Parkinson’s disease, improved BP and central and peripheral aortic stiffness over 4 weeks in adolescents with type 1 diabetes, researchers reported.
PCPs farther away from endocrinologists more often prescribe continuous glucose monitoring
Primary care physicians who practice farther away from endocrinologists were more likely to have prescribed continuous glucose monitoring for patients with diabetes, a study found.
Insulin resistance, hyperinsulinemia primary drivers of atherosclerotic CVD
Underlying insulin resistance and hyperinsulinemia work together as “bad actors” to drive atherosclerotic CVD long before a person is diagnosed with type 2 diabetes, and early treatment is needed to slow the process, according to a speaker.
Survey identifies diabetes care opportunities, challenges to address for future strategies
The 2021 National Practice and Workforce Survey published in The Science of Diabetes Self-Management and Care identified opportunities and challenges in diabetes care that can guide strategies for future workforce and practice settings.
Dialogues in Diabetes – Advances in Diabesity Management: A Closer Look at Incretin-Based Multiagonist Therapy (Issue 2)
This activity is supported by an educational grant from Lilly.
Multidisciplinary WCIRDC meeting honors cardiometabolic research pioneer
The 20th annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease will offer a unique blend of basic and clinical science across cardiometabolic disciplines while also providing practical implications for patient care.
Proposed revisions to Diabetes Distress Scale to benefit Spanish speakers
Study results published in The Science of Diabetes Self-Management and Care highlight the need to revise the Diabetes Distress Scale for Spanish-speaking people with diabetes to improve understanding and focused responses.
PREDICT3c study highlights risk factors for diabetes development in chronic pancreatitis
Risk factors for type 2 diabetes and factors related to pancreatic disease were independent risk factors for diabetes development among adults with chronic pancreatitis, according to a cross-sectional study published in Diabetes Care.
Tobacco use, type 2 diabetes top risk factors for pancreatitis with obesity treatment
CHARLOTTE, N.C. — Tobacco use, type 2 diabetes and advanced chronic kidney disease increased the risk for acute pancreatitis after initiation of glucagon-like peptide-1 receptor agonists for weight loss, noted a presenter at the ACG Annual Scientific Meeting.
Nonsteroidal MRAs: Will finerenone take the throne?
Mineralocorticoid receptor antagonists disrupt the renin-angiotensin-aldosterone system and provide beneficial outcomes in several renin-angiotensin-aldosterone system-mediated disease states.